Leadership

Mr. Namit Rustagi, Director

• Mr. Namit is MB LLC’s Legal Counsel and advises MB Group’s companies worldwide. He has been with the Group for over 12 years with an overall experience of over 23 years in the areas of corporate finance, structured and conventional fundraising (listed/unlisted), cross-border transactions, commercial/legal negotiations, inbound and outbound mergers & acquisitions, litigation and corporate/tax structuring/restructuring.

Dr. Sanjay Sonar (Ph.D.), Co-Founder, President & Manager

• Over 30 years of experience in downstream and protein engineering.
• Ph.D. from Indian Institute of Technology, Bombay; Post-doctoral work at Boston University and MIT, Cambridge, (USA).
• Worked in a close collaboration with Nobel Laureate Har Gobind Khorana at MIT for 6 years.
• Holds over 100 patents.

Dr. Archana Krishnan, Whole-Time Director

• Over 20 years of experience in molecular biology, strain development and upstream process.
• Ph.D. from the Center of DNA Fingerprinting and Manipal University.
• Gold medalist at University of Baroda.
• Holds over 27 patents.

Imran Jamiluddin Shaikh, Director

• Mr. Imran Shaikh holds a Master’s degree in Management Studies and Bachelor’s degree in Biomedical engineering.
• He leads the healthcare investments at Oman Investment Authority.
• Prior to joining OIA, Imran worked for Barclays, Bank of America and Credit Suisse (London), where he focused on healthcare M&A and capital markets transactions across EMEA region.

Mr. Ali Abdullah Ali Al Aamri, Director

• Mr. Ali Abdullah Ali Al Aamri holds a Bsc in Accounting & Finance.
• He is in Private Equity at Oman Investment Authority, Oman.
• He has more than 10 years of experience in the field of Finance.

Mr. Mohammed Hamdan Saif Al Rubaie, Director

• Dr. Mohammed Hamdan Saif Al Rubaie is PhD in Regulatory Affairs from Cardiff University, United Kingdom.
• He is also Director General of Pharmaceutical Affairs and Drug Control – Ministry of Health, Oman.
• Dr. Mohammed Al Rubaie has over more than 20 years of experience in the field of Pharmaceuticals.

Mr. Rajesh Dalal, Independent Director

• Mr. Rajesh is a mechanical engineer from the prestigious IIT Madras, and holds an M.B.A. from Bajaj Institute, Bombay.
• Mr. Rajesh Dalal is a senior consultant to the Healthcare Industry in Asia.
• He has advised leading multinationals like Philips, Netherlands, Intuitive Surgicals, USA,  Alltech, USA etc.
• He has been the Venture Partner with OrbiMed Advisors, which is world’s largest fund focused on investments in Healthcare.
• He is currently an advisor to PE Funds like Tata Healthcare Fund.
• Mr. Rajesh has worked over 30 years with Johnson and Johnson. Rajesh has to his credit several pioneering initiatives that made healthcare more accessible to the masses.
• Mr. Rajesh has also been the Chairman of American Chamber of Commerce in India. He has spoken at international seminars at Leipzig, Lausanne and Washington.

Mr. Sushil Srivastava, Nominee Director

• Mr. Sushil Kumar is a veteran financial strategist with over 40 years of experience in global finance, investment, governance, and corporate leadership.
• As the former Group CFO of MB LLC Group, he oversaw multi-billion-dollar portfolios, optimized capital structures, corporate finance, project finance, merger & acquisitions and greenfield projects across diverse sectors including oil & gas, mining, engineering, hospitality, and luxury yacht manufacturing.

Abhishek Deshpande, CFO

• 25 years of national and international management experience.
• Responsible for management and administration of business operations.
• Chartered Accountant with management studies.